Karol Ford

Karol Ford is an experienced professional in the healthcare and diagnostic industries, currently serving as the Director of Corporate Accounts at Dynex Technologies, Inc. since August 2022. Previous roles include Clinical Transplant Specialist at Natera, where Ford contributed to the development of the Prospera cfDNA test, and Global Sales and Marketing Director for Genetic Services at Health Network Laboratories®. Key positions also encompass VP Sales and Marketing at Clinical Genomics, Sr. Director of Pediatric Sales and Regional Sales Director at Progenity, and various roles at Luminex and Qiagen, showcasing a strong background in sales, marketing strategy, and product development within molecular diagnostics and genetic testing. Ford holds a Bachelor of Business Administration from Oakland University and the University of Phoenix.